Boston An independent LDT provider

Press releases

December 2, 2015 | REGULATORY

Immunovia’s stock increased 60 percent on first day of trading on Nasdaq First North with a turnover of SEK 28.5 million

Read press release
November 26, 2015

Immunovia approved for trading on Nasdaq First North as of December 1st, 2015

Read press release
October 5, 2015

Immunovia, OHSU collaborating on early detection test for pancreatic cancer

Read press release
1 28 29 30